[go: up one dir, main page]

AU2001294719A1 - Secreted human proteins - Google Patents

Secreted human proteins

Info

Publication number
AU2001294719A1
AU2001294719A1 AU2001294719A AU9471901A AU2001294719A1 AU 2001294719 A1 AU2001294719 A1 AU 2001294719A1 AU 2001294719 A AU2001294719 A AU 2001294719A AU 9471901 A AU9471901 A AU 9471901A AU 2001294719 A1 AU2001294719 A1 AU 2001294719A1
Authority
AU
Australia
Prior art keywords
human proteins
secreted human
secreted
proteins
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001294719A
Inventor
Chandra Arvizu
Janice Au-Young
Mariah R. Baughn
Neil Burford
Narinder K. Chawla
Li Ding
Brendan M. Duggan
Vicki S. Elliott
Ameena R. Gandhi
Kimberly J. Gietzen
Rajagopal Gururajan
April J. A. Hafalia
Cynthia D. Honchell
Preeti Lal
Sally Lee
Dyung Aina M. Lu
Danniel B. Nguyen
Jennifer L. Policky
Jayalaxmi Ramkumar
Madhu S. Sanjanwala
Stephanie K. Sapperstein
Y. Tom Tang
Kavitha Thangavelu
Michael Thornton
Bao Tran
Catherine M. Tribouley
Bridget A. Warren
Yuming Xu
Monique G. Yao
Henry Yue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Publication of AU2001294719A1 publication Critical patent/AU2001294719A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AU2001294719A 2000-09-29 2001-09-25 Secreted human proteins Abandoned AU2001294719A1 (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US23686900P 2000-09-29 2000-09-29
US60/236,869 2000-09-29
US23981200P 2000-10-11 2000-10-11
US60/239,812 2000-10-11
US24010800P 2000-10-12 2000-10-12
US60/240,108 2000-10-12
US24128200P 2000-10-17 2000-10-17
US60/241,282 2000-10-17
US24221800P 2000-10-20 2000-10-20
US60/242,218 2000-10-20
PCT/US2001/030042 WO2002026982A2 (en) 2000-09-29 2001-09-25 Secreted human proteins

Publications (1)

Publication Number Publication Date
AU2001294719A1 true AU2001294719A1 (en) 2002-04-08

Family

ID=27540074

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001294719A Abandoned AU2001294719A1 (en) 2000-09-29 2001-09-25 Secreted human proteins

Country Status (6)

Country Link
US (1) US20040138414A1 (en)
EP (1) EP1370655A2 (en)
JP (1) JP2004528006A (en)
AU (1) AU2001294719A1 (en)
CA (1) CA2423424A1 (en)
WO (1) WO2002026982A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7271240B2 (en) 2001-03-14 2007-09-18 Agensys, Inc. 125P5C8: a tissue specific protein highly expressed in various cancers
US8647826B2 (en) 2001-03-14 2014-02-11 Agensys, Inc. Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer
US20070037204A1 (en) 2003-08-08 2007-02-15 Hiroyuki ABURANTAI Gene overexpressed in cancer
EP1652923B1 (en) * 2003-08-08 2011-10-12 Perseus Proteomics Inc. Gene overexpressed in cancer
US20090133135A1 (en) * 2005-06-01 2009-05-21 Evotec Neurosciences Gmbh Diagnostic and Therapeutic Target SLC39A11 Proteins for Neurodegenerative Diseases
GB0521488D0 (en) * 2005-10-21 2005-11-30 Ares Trading Sa Integral membrane protein
WO2015126523A1 (en) * 2014-02-21 2015-08-27 Clontech Laboratories, Inc. Spin columns comprising poly(acid) membrane separation matrices, and methods of making and using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999040100A1 (en) * 1998-02-09 1999-08-12 Human Genome Sciences, Inc. 45 human secreted proteins
JP2004507202A (en) * 1999-03-31 2004-03-11 キュラジェン　コーポレイション Nucleic acid containing an open reading frame encoding a polypeptide; "ORFX"
EP1514933A1 (en) * 1999-07-08 2005-03-16 Research Association for Biotechnology Secretory protein or membrane protein
EP1130094A3 (en) * 1999-07-08 2001-11-21 Helix Research Institute Primers for synthesizing full length cDNA clones and their use

Also Published As

Publication number Publication date
CA2423424A1 (en) 2002-04-04
US20040138414A1 (en) 2004-07-15
WO2002026982A2 (en) 2002-04-04
JP2004528006A (en) 2004-09-16
EP1370655A2 (en) 2003-12-17
WO2002026982A3 (en) 2003-09-25

Similar Documents

Publication Publication Date Title
AU2002354719A1 (en) Human secreted proteins
AU2001237958A1 (en) 22 human secreted proteins
AU2002309513A1 (en) Human secreted proteins
AU2002233994A1 (en) Secreted proteins
AU2001227833A1 (en) 71 human secreted proteins
AU2002232596A1 (en) Secreted human proteins
AU2001270045A1 (en) Secreted proteins
AU2001245308A1 (en) 207 human secreted proteins
AU2001237957A1 (en) 17 human secreted proteins
AU2001255320A1 (en) Secreted proteins
AU4338100A (en) Secreted human proteins
AU2001294719A1 (en) Secreted human proteins
AU2001229507A1 (en) 21 human secreted proteins
AU2001255668A1 (en) 29 human secreted proteins
AU2001283327A1 (en) 8 human secreted proteins
AU2001229366A1 (en) Secreted proteins
AU2002365153A1 (en) 41 human secreted proteins
AU2001239729A1 (en) 22 human secreted proteins
AU2001229503A1 (en) 17 human secreted proteins
AU2001229563A1 (en) 21 human secreted proteins
AU2002327176A1 (en) 20 human secreted proteins
AU2001230942A1 (en) 7 human secreted proteins
AU2001288231A1 (en) Human secreted protein, zzp1
AU2001264869A1 (en) Human secreted protein, zsig47
AU2002246998A1 (en) 50 human secreted proteins